Virus Microscope

NanoVir Reports How Its HPV-Killer Works

NanoVir LLC of Kalamazoo, in partnership with the University of Missouri-St. Louis, has announced the results of a study that characterized the mechanism by which their novel antiviral compounds to prompt cells to selectively destroy human papillomavirus DNA.

WWJ Newsradio 950–10/02/2013

Kalamazoo Pharma Firm Gets $3 Million From NIH

Kalamazoo-based NanoVir LLC said Tuesday it had received a three-year, $3 million grant from the National Institutes of Health for its research on new antiviral drugs. The candidate drugs are “broad spectrum,” designed to fight […]